Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 4
Cost effectiveness and cost utility of the noncoding blood glucose meter CONTOUR® TS
Authors Przemyslaw Holko, Kawalec P
Published 10 February 2011 Volume 2011:4 Pages 79—88
DOI https://doi.org/10.2147/DMSO.S9395
Review by Single anonymous peer review
Peer reviewer comments 6
Przemyslaw Holko, Pawal Kawalec
HTA Centre, Kraków, Poland
Aims: This study assessed the cost efficacy and cost utility of the automatic blood glucose meter CONTOUR® TS from the public payer (National Health Fund [NHF]) and payer (patient and NHF) perspectives over a 26-year analysis horizon.
Methods: Clinical effectiveness data were obtained from prior clinical studies of automatic versus manually coded blood glucose meters. Cost data were obtained from the NHF. The probability of procedure use related to diabetic complications was obtained from four medical centers in Poland. The incremental cost-effectiveness ratio related to 1 life year gained and the incremental cost-utility ratio related to 1 quality-adjusted life year gained were calculated.
Results: Assuming co-funding from public funds, introduction of the CONTOUR® TS is associated with savings of Polish złoty (PLN) 31,846.19 (€8916.93) and PLN 113,018.19 (€31,645.09) per life year gained from the payer and public payer perspectives, respectively. Cost utility analyses showed that the CONTOUR® TS is associated with savings of PLN 40,465.59 (€11,330.37) and PLN 11,434.82 (€3201.75) per quality-adjusted life year gained from the payer and the public payer perspectives, respectively.
Conclusion: The CONTOUR® TS appears superior to manually coded meters available in Poland both from the payer and the public payer perspectives and may represent an improved strategy for glycemic control.
Keywords: blood glucose self monitoring, costs and cost analysis, health care costs, diabetes mellitus, diabetes complications
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.